We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GMP Deficiencies Spark CRL for French Drugmaker
Nicox, an international ophthalmic R&D company, announced it received a complete response letter related to its NDA for its cetirizine eye drop formulation AC-170.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor